Table 3. Susceptibility of ESBLs to Antibiotic Combination.
E. coli | K. pneumoniae | |
---|---|---|
Pip-Taz + AK | 98.1 | 93.1 |
Pip-Taz + GN | 73.7 | 61.4 |
CIP + AK | 96.7 | 91.1 |
CIP + GN | 41.2 | 51.5 |
Pip-Taz: Piperacillin-Tazobactam; CIP: Ciprofloxacin; Cefe: Cefepime; GN: Gentamicin; AK: Amikacin